Sek Kathiresan

Program Director

Sek Kathiresan, MD, Co-founder and CEO, Verve Therapeutics; Professor of Medicine, Harvard Medical School (on leave)
graphic of dna editing

Related Upcoming Webinar

Interested in this program? Join Program Director Sek Kathiresan for a short webinar presentation on March 12.

Request More Information